Location: Home
  • search
  • go
  • Relate News
  • 10/9/2023MNCs Wary of Pouring Big Investments in China While Actively Seeking L...
  • 10/9/2023NHSA Solicits Comments on Draft of the Guiding Opinions on Strengtheni...
  • 10/8/2023Recent Executive Movements
  • 10/8/2023PharmaEssentia Enters Global License Deal with WuXi Bio for a Myeloid ...
  • 10/7/2023CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
  • 10/4/2023PharmCube: Review of Chinese Hospital Drug Market MAT Q2/2023 (1)
  • 10/4/2023Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023
  • 10/3/2023CNIPA Invalides Novo's Core Chinese Patent for Semaglutide as Petition...
  • 9/29/2023Recent Executive Moves
  • 9/29/2023Financial-related Company News Digest (September 2023)
  • 9/28/2023Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...
  • 9/28/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
  • 9/28/2023CDE Solicits Comments on the Technical Guidelines for Clinical Efficac...
  • 9/26/2023China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...
  • 9/26/2023China Becomes Country with Highest and Increasingly Younger Alzheimer ...
  • 9/26/2023SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...
  • 9/26/2023WuXi Debuts First Vaccine CDMO Site in China
  • 9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
  • 9/25/2023AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space
  • 9/25/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...
  • 9/24/2023PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...
  • 9/24/2023Strategies for Asian Business Navigating a New Era (McKinsey)
  • 9/24/2023Improving Access to Medicines and Beyond: the National Volume-based Pr...
  • 9/21/2023Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...
  • 9/21/2023Recent Executive Moves
  • 9/20/2023NHSA Clears Two Additional Drugs from Form Evaluation for 2023 NRDL In...
  • 9/20/2023Everest Medicines Enters into Collaboration and License Agreement with...
  • 9/20/2023IQVIA: Chinese Hospital Drug Market Rebounded in MAT Q2/2023
  • 9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
  • Page:18/333 Total number of articles:9987: [First][<<] [16] [17] [18] [19] [20] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group